Platform Trials, Master Protocols, And Challenges In Execution

By Esha Senchaudhuri

How can we build an efficient statistical protocol for a clinical trial, if we do not know the therapies that will be tested nor the populations on whom the testing will occur? This is the challenge confronting those working to design an ever-increasing number of platform trials. In a recent webinar, Dr. Kyle Wathen, Cytel's Vice President of Scientific Strategy and Innovation, discussed a method using platform trials to show how to build such trials.